vs

Side-by-side financial comparison of GERON CORP (GERN) and SolarMax Technology, Inc. (SMXT). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $46.6M, roughly 1.0× SolarMax Technology, Inc.). SolarMax Technology, Inc. runs the higher net margin — -1.9% vs -39.0%, a 37.1% gap on every dollar of revenue. On growth, SolarMax Technology, Inc. posted the faster year-over-year revenue change (623.5% vs 67.1%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.

GERN vs SMXT — Head-to-Head

Bigger by revenue
GERN
GERN
1.0× larger
GERN
$47.2M
$46.6M
SMXT
Growing faster (revenue YoY)
SMXT
SMXT
+556.4% gap
SMXT
623.5%
67.1%
GERN
Higher net margin
SMXT
SMXT
37.1% more per $
SMXT
-1.9%
-39.0%
GERN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
SMXT
SMXT
Revenue
$47.2M
$46.6M
Net Profit
$-18.4M
$-872.2K
Gross Margin
2.7%
Operating Margin
-29.4%
-2.7%
Net Margin
-39.0%
-1.9%
Revenue YoY
67.1%
623.5%
Net Profit YoY
30.3%
77.7%
EPS (diluted)
$-0.03
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
SMXT
SMXT
Q4 25
$46.6M
Q3 25
$47.2M
$30.6M
Q2 25
$49.0M
$6.9M
Q1 25
$39.6M
$6.9M
Q4 24
$6.4M
Q3 24
$28.3M
$6.3M
Q2 24
$882.0K
Q1 24
$304.0K
Net Profit
GERN
GERN
SMXT
SMXT
Q4 25
$-872.2K
Q3 25
$-18.4M
$-2.3M
Q2 25
$-16.4M
$-1.9M
Q1 25
$-19.8M
$-1.3M
Q4 24
$-3.9M
Q3 24
$-26.4M
$-9.6M
Q2 24
$-67.4M
Q1 24
$-55.4M
Gross Margin
GERN
GERN
SMXT
SMXT
Q4 25
2.7%
Q3 25
3.1%
Q2 25
8.8%
Q1 25
20.5%
Q4 24
14.5%
Q3 24
19.9%
Q2 24
Q1 24
Operating Margin
GERN
GERN
SMXT
SMXT
Q4 25
-2.7%
Q3 25
-29.4%
-6.9%
Q2 25
-25.4%
-25.7%
Q1 25
-42.2%
-16.7%
Q4 24
-27.9%
Q3 24
-99.8%
-158.4%
Q2 24
-7860.9%
Q1 24
-18465.1%
Net Margin
GERN
GERN
SMXT
SMXT
Q4 25
-1.9%
Q3 25
-39.0%
-7.4%
Q2 25
-33.4%
-27.6%
Q1 25
-50.1%
-18.7%
Q4 24
-60.6%
Q3 24
-93.5%
-152.0%
Q2 24
-7639.8%
Q1 24
-18220.4%
EPS (diluted)
GERN
GERN
SMXT
SMXT
Q4 25
$-0.02
Q3 25
$-0.03
$-0.04
Q2 25
$-0.02
$-0.04
Q1 25
$-0.03
$-0.03
Q4 24
$-0.07
Q3 24
$-0.04
$-0.21
Q2 24
$-0.10
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
SMXT
SMXT
Cash + ST InvestmentsLiquidity on hand
$78.1M
$8.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
$-12.2M
Total Assets
$567.4M
$91.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
SMXT
SMXT
Q4 25
$8.0M
Q3 25
$78.1M
$5.7M
Q2 25
$77.7M
$1.9M
Q1 25
$83.7M
$6.8M
Q4 24
$7.1M
Q3 24
$60.3M
$8.6M
Q2 24
$116.9M
Q1 24
$189.8M
Stockholders' Equity
GERN
GERN
SMXT
SMXT
Q4 25
$-12.2M
Q3 25
$248.7M
$-11.8M
Q2 25
$259.5M
$-15.1M
Q1 25
$268.2M
$-15.9M
Q4 24
$-15.1M
Q3 24
$292.3M
$-10.9M
Q2 24
$306.7M
Q1 24
$344.9M
Total Assets
GERN
GERN
SMXT
SMXT
Q4 25
$91.3M
Q3 25
$567.4M
$58.7M
Q2 25
$555.2M
$38.2M
Q1 25
$562.5M
$38.6M
Q4 24
$38.6M
Q3 24
$444.9M
$43.0M
Q2 24
$449.4M
Q1 24
$482.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
SMXT
SMXT
Operating Cash FlowLast quarter
$-13.6M
$-2.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
SMXT
SMXT
Q4 25
$-2.5M
Q3 25
$-13.6M
$3.4M
Q2 25
$-27.4M
$220.7K
Q1 25
$-48.0M
$-601.1K
Q4 24
$-1.3M
Q3 24
$-58.9M
$203.6K
Q2 24
$-53.5M
Q1 24
$-62.3M
Free Cash Flow
GERN
GERN
SMXT
SMXT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
FCF Margin
GERN
GERN
SMXT
SMXT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Capex Intensity
GERN
GERN
SMXT
SMXT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
0.0%
Q2 24
23.4%
Q1 24
202.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GERN
GERN

Segment breakdown not available.

SMXT
SMXT

Yabucoa$35.9M77%
Other$10.7M23%

Related Comparisons